Peter Barrett Net Worth - Insider Trades and Bio as of Apr 27, 2026

Peter Barrett's Net Worth

$41.6 Million

Estimate Recalculated Nov 1, 2024 11:30AM EST

Who is Peter Barrett

Peter Barrett has an estimated net worth of $41.6 Million. This is based on reported shares across multiple companies, which include REVVITY, INC., ALNYLAM PHARMACEUTICALS INC, ZAFGEN, INC., SYNLOGIC, INC., MOMENTA PHARMACEUTICALS INC, SCICLONE PHARMACEUTICALS INC, Vitae Pharmaceuticals, Inc, and HELICOS BIOSCIENCES CORP.

SEC CIK

Peter Barrett's CIK is 0001291895

Past Insider Trading and Trends

2017 was Peter Barrett's most active year for acquiring shares with 8 total transactions. Peter Barrett's most active month to acquire stocks was the month of April. 2004 was Peter Barrett's most active year for disposing of shares, totalling 14 transactions. Peter Barrett's most active month to dispose stocks was the month of May. 2017 saw Peter Barrett paying a total of $457,917.74 for 79,237 shares, this is the most they've acquired in one year. In 2020 Peter Barrett cashed out on 12,302 shares for a total of $756,038.27, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REVVITY, INC.

Investor

Updated May 02, 2024

View Quote Details


Form 4	10.25%	2.19K	—	—	May 02, 2024	23.60K	Grant	—	May 01
Form 4	8.84%	1.74K	—	—	May 17, 2023	21.41K	Grant	—	May 15
Form 4	7.39%	1.35K	—	—	May 09, 2022	19.67K	Grant	—	May 06
Form 4	-21.45%	-5.00K	—	—	Aug 02, 2021	18.31K	Grant	—	Jul 30
Form 4	5.97%	1.31K	—	—	May 10, 2021	23.31K	Grant	—	May 07
Form 4	-25.55%	-7.55K	$71.10	-$556.13K	May 29, 2020	22.00K	Sale	—	May 28
Form 4	10.23%	2.30K	$92.20	$27.48K	May 12, 2020	24.80K	Grant	—	May 08
Form 4	-4.07%	-955.00	—	—	Nov 12, 2019	22.50K	Grant	—	Nov 11
Form 4	8.45%	1.83K	—	—	May 01, 2019	23.46K	Grant	—	Apr 30
Form 4	-10.21%	-5.60K	$62.07	-$353.48K	Feb 14, 2019	49.26K	Sale	—	Feb 13
Form 4	12.65%	2.43K	—	—	May 04, 2018	21.63K	Grant	—	May 03
Form 4	-26.92%	-7.07K	$49.43	-$306.10K	Nov 14, 2017	19.20K	Sale	—	Nov 13
Form 4	-34.25%	-10.00K	$44.69	-$370.78K	Jun 02, 2017	19.20K	Sale	—	Jun 01
Form 4	17.09%	2.80K	—	—	May 10, 2017	19.20K	Grant	—	May 09
Form 4	11.51%	3.19K	—	—	May 12, 2016	30.96K	Grant	—	May 10
Form 4	29.82%	3.03K	—	—	May 07, 2015	13.20K	Grant	—	May 05
Form 4	91.34%	7.12K	—	—	May 01, 2014	14.92K	Grant	—	Apr 29
Form 4	195.46%	8.86K	—	—	May 02, 2013	13.40K	Grant	—	Apr 30
Form 4	1,115.29%	10.65K	—	—	May 03, 2012	11.61K	Grant	—	May 01
Form 4	—	10.96K	—	—	Feb 09, 2012	10.96K	Grant	—	Feb 07
Form 3	—	—	—	—	Feb 06, 2012	—	—	—	—

Showing 21 results

ALNYLAM PHARMACEUTICALS INC

Investor

Updated Jun 16, 2006

View Quote Details


Form 4/A	—	10.00K	—	—	Jun 16, 2006	10.00K	Grant	—	Jun 01
Form 4	—	10.00K	—	—	Jun 02, 2006	10.00K	Grant	—	Jun 01
Form 4	-4.15%	-21.80K	$16.51	-$359.83K	Mar 09, 2006	503.53K	Sale	—	Mar 07
Form 4	-31.54%	-241.98K	$17.04	-$4.11M	Mar 07, 2006	525.33K	Sale	—	Mar 03 - Mar 06
Form 4	-15.16%	-137.10K	$16.06	-$2.20M	Mar 03, 2006	767.32K	Sale	—	Mar 01 - Mar 02
Form 4	-27.41%	-341.55K	$15.88	-$5.41M	Mar 01, 2006	904.42K	Sale	—	Feb 27 - Feb 28
Form 4	-6.84%	-91.50K	$14.97	-$1.36M	Feb 27, 2006	1.25M	Sale	—	Feb 23 - Feb 24
Form 4	-33.32%	-668.54K	—	—	Oct 03, 2005	1.34M	Disposition	—	Sep 29
Form 4	—	10.00K	—	—	Jun 10, 2005	10.00K	Grant	—	Jun 08
Form 4	-44.45%	-1.61M	—	—	Jun 07, 2004	2.01M	Options	—	Jun 03
Form 4/A	—	222.50K	$6.00	$1.34M	Jun 07, 2004	222.50K	Purchase	—	May 27 - Jun 01
Form 4	—	222.50K	$6.00	$1.34M	Jun 01, 2004	222.50K	Purchase	—	May 27 - Jun 01
Form 3	—	—	—	—	May 27, 2004	—	—	—	—

Showing 13 results

ZAFGEN, INC.

Investor

Updated May 12, 2022

View Quote Details


Form 4	—	8.30K	—	—	May 12, 2022	8.30K	Grant	—	May 10
Form 4	—	8.30K	—	—	May 17, 2021	8.30K	Grant	—	May 12
Form 4	—	16.60K	—	—	Sep 30, 2020	16.60K	Grant	—	Sep 29
Form 4	—	27.00K	—	—	Jun 27, 2019	27.00K	Grant	—	Jun 26
Form 4	—	21.40K	—	—	Jan 28, 2019	21.40K	Grant	—	Jan 24
Form 4	—	20.00K	—	—	Jun 07, 2018	20.00K	Grant	—	Jun 06
Form 4	—	17.63K	—	—	Jan 05, 2018	17.63K	Grant	—	Jan 03
Form 4	—	14.50K	—	—	Jun 23, 2017	14.50K	Grant	—	Jun 21
Form 4	—	24.86K	—	—	Feb 14, 2017	24.86K	Grant	—	Feb 13
Form 4	—	12.00K	—	—	Jul 01, 2016	12.00K	Grant	—	Jun 30
Form 4	0.19%	8.85K	$7.91	$70.00K	Jan 27, 2016	4.64M	Grant	—	Jan 25
Form 4	—	12.00K	—	—	Jul 15, 2015	12.00K	Grant	—	Jul 13
Form 4	0.03%	1.75K	$40.04	$69.99K	Jan 12, 2015	5.63M	Grant	—	Jan 08
Form 4	-84.08%	-29.74M	—	—	Jun 26, 2014	5.63M	Options	—	Jun 24
Form 3	—	—	—	—	Jun 18, 2014	—	—	—	—

Showing 15 results

SYNLOGIC, INC.

Investor

Updated Jan 04, 2024

View Quote Details


Form 4	—	24.92K	—	—	Jan 04, 2024	24.92K	Grant	—	Jan 02
Form 4	—	30.00K	—	—	Jun 26, 2023	30.00K	Grant	—	Jun 22
Form 4	—	156.13K	—	—	Jan 04, 2023	156.13K	Grant	—	Jan 03
Form 4	—	27.00K	—	—	Jun 13, 2022	27.00K	Grant	—	Jun 09
Form 4	—	49.33K	—	—	Jan 05, 2022	49.33K	Grant	—	Jan 03
Form 4	—	12.82K	—	—	Jun 14, 2021	12.82K	Grant	—	Jun 10
Form 4	—	57.50K	—	—	Jan 05, 2021	57.50K	Grant	—	Jan 04
Form 4	—	1.54K	—	—	Jul 28, 2020	1.54K	Grant	—	Jul 24
Form 4	—	48.66K	—	—	Jul 28, 2020	48.66K	Grant	—	Jan 02
Form 4	—	15.00K	—	—	Jun 08, 2020	15.00K	Grant	—	Jun 04
Form 4	—	10.00K	—	—	Jun 07, 2019	10.00K	Grant	—	Jun 05
Form 4	—	17.38K	$4.39	$76.30K	Apr 09, 2019	17.38K	Grant	—	Jan 02
Form 4	—	10.00K	—	—	Jun 14, 2018	10.00K	Grant	—	Jun 13
Form 4	—	28.71K	$6.60	$76.36K	Jan 03, 2018	28.71K	Grant	—	Dec 29 - Jan 02
Form 4	—	2.86K	—	—	Aug 30, 2017	2.86K	Grant	—	Aug 28
Form 3	—	—	—	—	Aug 30, 2017	2.65M	—	—	—

Showing 16 results

MOMENTA PHARMACEUTICALS INC

Investor

Updated Jun 09, 2008


Form 4	25.00%	19.20K	—	—	Jun 09, 2008	96.00K	Grant	—	Jun 05
Form 4/A	33.33%	19.20K	—	—	Jul 17, 2007	76.80K	Grant	—	Jun 13
Form 4	33.33%	19.20K	—	—	Jun 15, 2007	76.80K	Grant	—	Jun 13
Form 4	50.00%	19.20K	—	—	Jun 16, 2006	57.60K	Grant	—	Jun 15
Form 4	-19.15%	-582.43K	—	—	Aug 05, 2005	2.46M	Disposition	—	Aug 03
Form 4	-20.00%	-760.48K	—	—	Jul 07, 2005	3.04M	Disposition	—	Jul 05
Form 4	—	38.40K	—	—	May 27, 2005	38.40K	Grant	—	May 26
Form 4	23.82%	731.39K	—	—	Jun 29, 2004	3.80M	Options	—	Jun 25
Form 4	—	122.00K	$6.50	$793.00K	Jun 24, 2004	122.00K	Purchase	—	Jun 21
Form 3	—	—	—	—	Jun 23, 2004	—	—	—	—

Showing 10 results

SCICLONE PHARMACEUTICALS INC

Investor

Updated Jun 11, 2012


Form 4	—	30.00K	—	—	Jun 11, 2012	30.00K	Grant	—	Jun 07
Form 4	—	5.00K	—	—	Jul 05, 2011	5.00K	Grant	—	Jun 30
Form 4	—	50.00K	—	—	Apr 20, 2011	50.00K	Grant	—	Apr 18
Form 3	—	—	—	—	Apr 20, 2011	1.97M	—	—	—

Showing 4 results

Vitae Pharmaceuticals, Inc

Investor

Updated Oct 01, 2014


Form 4	3.30%	37.50K	$8.00	—	Oct 01, 2014	1.17M	Purchase	—	Sep 29
Form 4	—	17.00K	—	—	Sep 26, 2014	17.00K	Grant	—	Sep 24
Form 3	—	—	—	—	Sep 24, 2014	—	—	—	—

Showing 3 results

HELICOS BIOSCIENCES CORP

Investor

Updated Sep 22, 2009


Form 4	3.48%	403.75K	—	—	Sep 22, 2009	12.01M	Purchase	—	Sep 18
Form 4	—	5.55K	—	—	Aug 10, 2009	5.56K	Grant	—	Aug 06
Form 4	461.65%	13.79M	—	—	Dec 29, 2008	16.78M	Purchase	—	Dec 23
Form 4	—	5.55K	—	—	Jun 13, 2008	5.56K	Grant	—	Jun 11
Form 4	—	11.11K	—	—	Jul 31, 2007	11.11K	Grant	—	Jul 27
Form 4	-74.99%	-8.96M	$9.00	—	May 31, 2007	2.99M	Buy-Options	—	May 30
Form 3	—	—	—	—	May 24, 2007	—	—	—	—

Showing 7 results